SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
By
Cardiometabolic Health Congress (CMHC)
FEATURING
Lance Sloan
By
Cardiometabolic Health Congress (CMHC)
FEATURING
Lance Sloan
9,385 views
June 17, 2019
Comments 3
Login to view comments.
Click here to Login